GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (GREY:BAIVF) » Definitions » Other Long Term Assets

Benevolent AI (Benevolent AI) Other Long Term Assets : $2.61 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Benevolent AI Other Long Term Assets?

Benevolent AI's other long-term assets for the quarter that ended in Dec. 2023 was $2.61 Mil.

Benevolent AI's quarterly other long-term assets increased from Dec. 2022 ($2.31 Mil) to Jun. 2023 ($2.39 Mil) and increased from Jun. 2023 ($2.39 Mil) to Dec. 2023 ($2.61 Mil).

Benevolent AI's annual other long-term assets declined from Dec. 2021 ($3.40 Mil) to Dec. 2022 ($2.31 Mil) but then increased from Dec. 2022 ($2.31 Mil) to Dec. 2023 ($2.61 Mil).


Benevolent AI Other Long Term Assets Historical Data

The historical data trend for Benevolent AI's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI Other Long Term Assets Chart

Benevolent AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial 3.30 3.39 3.40 2.31 2.61

Benevolent AI Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only 3.40 3.15 2.31 2.39 2.61

Benevolent AI Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Benevolent AI (Benevolent AI) Business Description

Comparable Companies
Traded in Other Exchanges
Address
4-8 Maple Street, London, GBR, W1T 5HD
Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.